Rick Wenstrup

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.”.

Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.183

N/A

0DataRank · unranked

2 citations

Susan Halabi, Joseph D. Schonhoft, Jun Luo, David M. Nanus, Paraskevi Giannakakou +13 more

AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.184

N/A

0DataRank · unranked

1 citations

Jun Luo, Monika Anand, Emmanuel S. Antonarakis, David M. Nanus, Paraskevi Giannakakou +10 more

Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis

npj Precision Oncology(2021)10.1038/s41698-021-00211-1

N/A

0DataRank · unranked

34 citations

Sheng-Yu Ku, Luisa Fernandez, Angel Dago-Rodriquez, Jerry S. H. Lee, Adam Jendrisak +11 more

Schlafen 11 (SLFN11), a putative predictive biomarker of platinum/PARPi response, is frequently detected on circulating tumor cells (CTCs) in advanced prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17039

N/A

0DataRank · unranked

4 citations

Luisa Fernandez, Kate Cunningham, Natalie Elphick, Ethan Barnett, Jerry S. H. Lee +11 more

Chromosomal instability (CIN) in circulating tumor cells (CTC) predicts for taxane sensitivity in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5026

N/A

0DataRank · unranked

0 citations

Andrea Arfè, Ethan Barnett, Erica Simone Dayan, Jimmy L. Zhao, Emily Carbone +5 more

Prognostic impact of circulating tumor cells in oligometastatic hormone-sensitive prostate cancer following metastasis-directed therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.199

N/A

0DataRank · unranked

1 citations

Philip Sutera, Ryan Phillips, Mathew Pierre Deek, Noura Radwan, Catherine H. Marshall +15 more